Disease control of differentiated thyroid carcinomas by hemithyroidectomy

Singapore Medical Journal

Volumn 51, Issue 4, 2010, Pages 311-314

  Chow, T L ^a   Choi, C Y ^a   Lam, S H ^a  

^a UNITED CHRISTIAN HOSPITAL   (Hong Kong)

Author keywords

Central compartment; Differentiated thyroid carcinoma; Hemithyroidectomy

Indexed keywords

ADULT; ARTICLE; CANCER CONTROL; CANCER RECURRENCE; CANCER REGISTRY; DIFFERENTIATED THYROID CARCINOMA; FEMALE; FOLLOW UP; HEMITHYROIDECTOMY; HISTOPATHOLOGY; HUMAN; HURTHLE CELL CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORBIDITY; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TUMOR VOLUME; VOCAL CORD PARALYSIS; CARCINOMA; HONG KONG; MIDDLE AGED; ONCOLOGY; PROCEDURES; REGISTER; THYROID NEOPLASMS; TREATMENT OUTCOME;

ADULT; CARCINOMA; FEMALE; FOLLOW-UP STUDIES; HONG KONG; HUMANS; LYMPHATIC METASTASIS; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 77953515185     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Mazzaferri EL, Young EL. Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med 1981; 70:511-8.
2. Clark OH. Total thyroidectomy. The treatment of choice for patients with differentiated thyroid cancer. Ann Surg 1982;196:361-8.
3. Samaan NA, Maheshwari YK, Nader S, et al. Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases. J Clin Endocrinol Metab 1983; 56:1131-8.
4. Degroot LJ, Kaplan EL, McCormick M, Straus FH. Natural history, treatment and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990; 71:414-24.
5. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993; 114:1050-7.
6. Shaha AR, Loree TR, Shah JP. Intermediate-risk group for differentiated carcinoma of thyroid. Surgery 1994; 116:1036-40.
7. Hay ID, Grant CS, Taylor WF, McConahey WM. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987; 102:1088-95.
8. Cady B. Our AMES is true: how an old concept still hit the mark: or, risk group assignment points the arrow to rational therapy selection in differentiated thyroid cancer. Am J Surg 1997; 174:462-8.
9. Shaha AR, Shah JP, Loree TR. Risk group stratification and prognostic factors in papillary carcinoma of thyroid. Ann Surg Oncol 1996; 3:534-8.
10. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988; 104:947-53.
11. Chow TL, Chu W, Lim BH, Kwok SP. Outcomes and complications of thyroid surgery: retrospective study. Hong Kong Med J 2001; 7:261-5.
12. Chow TL, Lim BH, Kwok SP. Sentinel lymph node dissection in papillary thyroid carcinoma. ANZ J Surg 2004; 74:10-2.
13. Chow TL, Venu V, Kwok SP. Use of fine-needle aspiration cytology and frozen section examination in diagnosis of thyroid nodules. Aust NZJ Surg 1999; 69:131-3.
14. Hedinger C, Wiiliam ED, Sobin LH. Histologic typing of the thyroid tumors 2nd ed, no. 11. In: International Histological Classification of Tumours, World Health Organization. New York: Springer-Verlag, 1988: 9-10.
15. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A national cancer data base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995.Cancer 1998; 83:2638-48.
16. Hay ID, Thompson GB, Grant CS, et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (19401999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 2002; 26:879-85.
17. Jonklaas J, Sarlis NJ, Litofsky D, et al. Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid 2006; 16:1229-42.
18. Bilimoria KY, Bentrem DJ, Ko CY, et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 2007; 246:375-81.
19. Pacini F, Schlumberger M, Dralle H, et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006; 154:787-803.
20. Grant CS, Hay ID, Gough IR, et al. Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important? Surgery 1988; 104:954-62.
21. Pacini F, Elisei R, Capezzone M, et al. Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients. Thyroid 2001; 11:877-81.
22. Hay ID, Grant CS, Bergstralh EJ, et al. Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery 1998; 124:958-64.
23. Sandars LE, Cady B. Differentiated thyroid cancer: reexamination of risk groups and outcome of treatment. Arch Surg 1998; 133:419-25.
24. Shaha AR, Shah JP, Loree TR. Low-risk differentiated thyroid cancer: the need for selective treatment. Ann Surg Oncol 1997; 4:328-33.
25. Shaha AR, Loree TR, Shah JP. Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery 1995; 118:1131-6.
26. Rao RS, Parikh HK, Deshmane VH, et al. Prognostic factors in follicular carcinoma of the thyroid: a study of 198 cases. Head Neck 1996; 18:118-24.
27. Sanders LE, Silverman M. Follicular and Hurthle cell carcinoma: predicting outcome and directing therapy. Surgery 1998; 124:967-74.
28. Lo CY, Chan WF, Lam KY, Wan KY. Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival. Ann Surg 2005; 242:708-15.
29. Gimm O, Rath FW, Dralle H. Pattern of lymph node metastases in papillary thyroid carcinoma. Br J Surg 1998; 85:252-4.
30. Sawka AM, Thephamongkhol K, Brouwers M, et al. Clinical Review 170: A systematic review and metaanalysis of the effectiveness of radiaoactive iodine remnant ablation for well-differentiated thyroid cancer. J Clin Endocrinol Metab 2004; 89:3668-76.
31. Chow SM, Yau S, Kwan CK, Poon PC, Law SC. Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition. Endocr Relat Cancer 2006; 13:1159-72.
32. White ML, Gauger PG, Doherty GM. Central lymph node dissection in differentiated thyroid cancer. World J Surg 2007; 31:895-904.